CovidResearchTrials by Shray Alag


CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)


Co-mestring (co-coping)Wiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (1)


Name (Synonyms) Correlation
drug1974 Quantra System Wiki 1.00

Correlated MeSH Terms (3)


Name (Synonyms) Correlation
D004211 Disseminated Intravascular Coagulation NIH 0.50
D020141 Hemostatic Disorders NIH 0.30
D001778 Blood Coagulation Disorders NIH 0.30

Correlated HPO Terms (2)


Name (Synonyms) Correlation
HP:0005521 Disseminated intravascular coagulation HPO 0.50
HP:0001928 Abnormality of coagulation HPO 0.30

There is one clinical trial.

Clinical Trials


1 Coping With 2020 - No Health Without Mental Health

The Corona pandemic is affecting the whole world and since March 12.th 2020 there has been strict qurantene and social isolation interventions in Norway. The aim of this intervention is to reduce the negative and fatal effects of the pandemic. The pandemic and the restrictions that follows it is assumed to affect the mental health of the general population. In this research project we want to examine the use and the effects of a digital self-guided psychological intervention with the aim to increase coping and to reduce psychological problems during and after the pandemic. The participants will be randomized to either an intensive group (new module every 3rd day) or to an ordinary group (new module every 5th day).

NCT04421612 Covid19, Anxiety, Worry Behavioral: Co-mestring (co-coping)

Primary Outcomes

Description: measures depression severity with nine items scored 0 ("not at all") to 3 ("nearly every day"), corresponding to the criteria for major depression in the DSM-5. The sum of the scores for the nine items ranges from 0 to 27

Measure: The Patient Health Questionnaire

Time: 6 months

Description: measures anxiety severity with seven items scored 0 ("not at all") to 3 ("nearly every day"). The total score ranges from 0 to 21

Measure: The Generalized Anxiety Disorder Scale

Time: 6 months

Secondary Outcomes

Description: In the instructions to the PANAS scales in the current study, participants were asked, ''To what extent do you generally feel this way, that is, how do you feel on average?'' Each PANAS scale comprises 10 specific mood-related adjectives, rated on a 5-point scale from not at all to very much

Measure: Positive and negative affect

Time: 6 months

Description: Widely used psychological instrument for measuring the perception of stress. It is a measure of the degree to which situations in one's life are appraised as stressful. Items were designed to tap how unpredictable, uncontrollable, and overloaded respondents find their lives.

Measure: Perceived Stress Scale

Time: 6 months

Description: structured survey used to assess level of satisfaction with care. Items are scored on a Likert scale from 1 (low satisfaction) to 4 (high satisfaction) with different descriptors for each response point. Total scores range from 8 to 32, with higher scores indicating greater satisfaction

Measure: Client Satisfaction Scale

Time: 6 months


No related HPO nodes (Using clinical trials)